Common questions about Flotac (FAQ)
Q: Does Flotac cause drowsiness or affect my ability to drive?
A: Official product information for diclofenac, the active ingredient in Flotac, documents potential central nervous system side effects such as dizziness and somnolence (drowsiness). Regulatory documents note that if these effects occur, activities requiring mental alertness, such as driving or operating heavy machinery, may be impaired.
Q: Can Flotac be taken on an empty stomach?
A: For specific formulations, such as the oral powder, official instructions require it to be mixed and consumed on an empty stomach. Taking other forms, like delayed-release tablets, with food is documented to delay how quickly the medicine is absorbed into the body.
Q: What is the approved use for Flotac in children or adolescents?
A: Regulatory information indicates that Flotac is generally approved for use in adults and adolescents ge 14 years of age for pain and inflammation. Dosage strengths designed for adults are generally not recommended for younger children, and eligibility requires evaluation based on official guidelines.
Q: Do official studies support the use of Flotac for back pain?
A: Official regulatory indications for diclofenac include the treatment of both acute and chronic musculoskeletal pain, which covers back pain. Some governmental guidelines specifically reference its use for managing certain types of back discomfort.
Q: What does the label mean by 'contraindications' for Flotac?
A: A contraindication is an official statement from regulatory bodies defining a condition or situation where the medicine must not be used because the potential risks are too high. These exclusions are established to prevent serious adverse outcomes, such as severe heart or gastrointestinal problems.
Q: What are the signs of an allergic reaction to Flotac?
A: Official documentation states that signs of a serious allergic reaction, also known as hypersensitivity, may include hives, an itchy rash, swelling of the eyelids, lips, or throat, or difficulty breathing (bronchospasm). These are defined as severe adverse reactions.
Q: What is the evidence level for Flotac’s use in joint pain?
A: Diclofenac is officially indicated for the relief of symptoms associated with inflammatory joint conditions, such as rheumatoid arthritis and osteoarthritis. This means the medicine is approved for these uses based on regulatory review of the available clinical evidence for its effect on joint pain and inflammation.
Q: Is there a maximum number of days I can use Flotac continuously?
A: Regulatory guidance emphasizes that the medicine should be used at the lowest effective dose for the shortest duration possible. Continuous long-term use is generally associated with increased risks of serious side effects, particularly involving the cardiovascular and gastrointestinal systems, but no fixed maximum number of days is universally specified.
Q: Does Flotac have a Black Box Warning in the US?
A: Yes, diclofenac carries an official Boxed Warning from the U.S. Food and Drug Administration (FDA). This warning highlights the potential for serious cardiovascular thrombotic events (like heart attack and stroke) and serious gastrointestinal adverse events (like bleeding and ulceration).
Q: How quickly does Flotac typically start working for general aches?
A: Official drug information and clinical data indicate that for certain chronic conditions, the full effects of the medicine may take up to one week of continuous use to become fully noticeable. For acute pain, the onset of effects is typically shorter, though this varies individually.
Q: How long does the effect of one dose of Flotac usually last?
A: The duration of effect depends on the specific formulation. For many oral, non-extended-release forms, the pain-relieving effects can last for up to 8 hours. This is related to the drug's relatively short elimination half-life, which is the time it takes for half the drug to leave the bloodstream.
Q: Do I need a prescription to get Flotac, or is it available over the counter?
A: Systemic oral forms of diclofenac, such as tablets and capsules, are generally classified as prescription-only medicines in the US and many other countries. This is due to the potential safety risks associated with the medicine, requiring professional supervision. However, certain topical forms may be available over the counter.
Q: What does the research say about Flotac for reducing inflammation?
A: Diclofenac is officially classified and used as an anti-inflammatory medicine. Its mechanism of action, as described in regulatory documents, is to interrupt the process of prostaglandin synthesis, which is a biological process involved in the body's inflammatory response.
Q: Are there any restrictions on alcohol consumption while taking Flotac?
A: Official warnings state that patients should avoid or limit alcohol consumption while using diclofenac. Alcohol may increase the risk of serious gastrointestinal side effects, such as stomach bleeding and ulcers, which is a documented risk of this medicine.
Q: What is the difference between Flotac capsules and tablets?
A: Regulatory documents describe different physical forms, including immediate-release (often capsules or tablets) and delayed-release tablets. These differences primarily affect the rate of absorption and, in turn, may dictate the necessary dosing frequency, such as being taken twice daily versus once daily.
Q: Does taking Flotac affect laboratory blood tests?
A: Yes, official safety information indicates that diclofenac may cause an elevation in liver enzyme levels in some patients, which can be detected in blood tests. Additionally, the medicine can affect the concentration of other drugs in the blood, such as lithium or methotrexate, by influencing their clearance.
Q: Does the drug Flotac contain any common allergens like lactose or gluten?
A: Official inactive ingredient lists, such as those found on regulatory labels, confirm that some oral formulations of diclofenac contain lactose monohydrate. Regulatory documents list all inactive components, but specific warnings about other allergens like gluten are not always universally detailed across all labels.
Q: Why is Flotac used by some people for migraine headaches?
A: Specific oral solution formulations of diclofenac are officially indicated and approved by regulatory bodies for the acute treatment of migraine attacks. This means clinical evidence supports its use for rapidly reducing migraine pain.
Q: What should I do if the drug doesn't seem to be working?
A: Regulatory guidance emphasizes that a patient's need for symptomatic relief and their response to therapy should be re-evaluated periodically by a healthcare professional. If the medicine does not provide adequate relief, official guidance suggests re-evaluation by a healthcare provider, rather than adjusting the use oneself.
Q: What does research suggest about Flotac's use in dental pain?
A: Some regulatory documents and guidelines specifically list the use of diclofenac for the management of acute pain conditions, which includes pain experienced following dental surgery or tooth extractions.
